Mefke TM 500mg/250mg Tablet
Marketer
Eskos Pharma
Salt Composition
Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Overview Mefke TM 500mg/250mg Tablet
Combifem 500mg/250mg tablets offer combined treatment for severe menstrual bleeding and associated pain. This medication works by inhibiting clot breakdown, thus reducing excessive menstrual flow. It also suppresses the production of pain-inducing and inflammatory mediators. Combifem 500mg/250mg tablets can be ingested with food at any time, though consistent daily timing is recommended, ideally commencing on the first day of menstruation for optimal efficacy. Continue taking the medication as directed by your physician for the prescribed duration. If a dose is missed, take it as soon as possible. Complete the entire course of treatment, even if symptoms improve. Consult your doctor if menstrual flow doesn't improve after three consecutive cycles. Common side effects include nausea, abdominal discomfort, headache, nasal congestion, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is recommended to prevent dehydration. Report any lack of improvement in menstrual flow after three consecutive cycles to your doctor. Before starting treatment, inform your doctor of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other medications you are currently taking. Regular eye examinations may be necessary during treatment. Alcohol consumption should be avoided while taking this medication.
Primary Ingredients of Mefke TM 500mg/250mg Tablet
No information provided. Unable to rephrase.
Uses of Mefke TM 500mg/250mg Tablet
Managing excessive menstrual flow and menstrual discomfort
Major Benefits of Mefke TM 500mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Mefke TM 500mg/250mg Tablet should be taken with a meal.
Common Side effects of Mefke TM 500mg/250mg Tablet:
- Nausea
- Vomiting
- Heartburn
- Indigestion
- Diarrhea
- Loss of appetite
- Nasal congestion (stuffy nose)
- Headache
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
- Stomach pain
- Sinus pain
- Sinus inflammation
How to use Mefke TM 500mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mefke TM 500mg/250mg tablet should be administered with food.
How Mefke TM 500mg/250mg Tablet works:
Each Mefke TM 500mg/250mg tablet contains Tranexamic Acid and Mefenamic Acid, two active pharmaceutical ingredients. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, thereby reducing menstrual bleeding. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis, mitigating pain and inflammation associated with swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Mefke TM 500mg/250mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Mefke TM 500mg/250mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on current evidence, the use of Mefke TM 500mg/250mg tablets while breastfeeding appears to pose minimal risk to the infant. Available data from human studies indicate negligible danger to the nursing child.
DrivingUNSAFE
Taking Mefke TM 500mg/250mg tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Mefke TM 500mg/250mg tablets; dosage modification may be necessary. Physician consultation is advised. The use of Mefke TM 500mg/250mg tablets is contraindicated in patients with severe renal dysfunction.
LiverSAFE IF PRESCRIBED
Use of the Mefke TM 500mg/250mg Tablet in patients with liver disease appears to present a low risk. Current evidence indicates dose modification might be unnecessary, however, physician consultation is recommended.
What if you forget to take Mefke TM 500mg/250mg Tablet :
Should you forget a Mefke TM 500mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mefke TM 500mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently